Summary:Nebulizer is a medical device used for upper respiratory tract diseases, and it has now developed to the third generation of products - mesh nebulizer. From the market point of view, nebulization inhalation for the elderly, young children and other special groups of people to avoid the pain of intravenous and intramuscular injection, become the choice of respiratory diseases, with the popularity of nebulizer inhalation, the choice of medical nebulizer has gradually become the focus, and the supply and demand of the domestic nebulizer market has grown rapidly. According to the data, the production and demand of China's nebulized inhaler industry in 2022 will be about 10,000 units, with year-on-year growth. 3%。Among them, the compression atomizer market has the fastest growth rate, and the market demand for compression atomizers will reach 10.18 million units in 2022.
OneDefinitionsand classification
Nebulizer (nebulizer) is a medical device used for upper respiratory tract diseases to convert liquid medicine into a nebulized form of fine particles so that the patient can breathe the drug into the respiratory tract and lungs. This is an effective way to deliver the drug to the respiratory system, especially in respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD).
The classification of nebulizers can be classified according to the working principle, use and delivery method, and the common classification according to the application field includes household and medical;According to the basic principle, it includes three forms: compressed air, ultrasonic, and vibrating net atomizer;In addition, depending on whether it can be reused, it includes disposable nebulizers and non-disposable nebulizers.
IIBusiness model
Procurement model
Atomizer enterprises mainly adopt the procurement mode of combining "planned production" and "sales and production", and arrange procurement plans and production schedules according to specific orders, parts procurement cycles, production and processing cycles and other factors. For standardized raw materials, raw materials with long lead times, and fragile materials for transportation, enterprises set safety stocks. In order to ensure the quality of the purchased products, the company has established the corresponding procurement process control procedures, and the R&D center is responsible for the preparation of technical requirements for purchased materialsThe Ministry of Materials is responsible for the regular evaluation of the production, service and qualification of the first business.
Production mode
Atomizer enterprises also mainly take the "planned production" and "sales production" combination of production methods, at the beginning of the period according to the previous sales situation to develop safety stocks, when the inventory of goods is lower than the amount of safety stock enterprises will increase production to make up for the inventory, during the period according to the order to develop a production plan, the production plant in strict accordance with the production plan and safety stock standards to organize production, the quality management department is responsible for the production process of quality control points and process operation specifications for supervision and inspection. In order to ensure the timeliness of delivery, large-scale enterprises in the industry will produce a certain amount of general self-made parts and products in advance to ensure the safe number of stock, improve market response ability, and meet customer needs in a timely manner.
Sales model
There are two main types of enterprises in the industry: offline sales and online sales. The offline business is mainly based on the "distribution model, supplemented by the direct sales model" for external sales. Under the distribution model, the relevant enterprises adopt the buyout sales method for the dealers, and the dealers will obtain the ownership of the products after purchasing the company's products, and the company will recognize the revenue after the products are out of the warehouse; In the direct sales model, the company signs sales orders with hospitals to reduce product intermediary costs and maximize customer benefits. The online business adopts a direct sales model. At present, enterprises in the industry mainly sell products to end consumers through online shopping platforms such as Tmall and JD.com, and relevant enterprises obtain sales statements from e-commerce sales platforms every month, and confirm sales revenue after being checked by both parties.
IIIindustrypolicy
Due to the increasingly severe global aging population and the increasing prevalence of chronic diseases, the growing clinical demand for medical devices has promoted the sustainable development of the global medical device market. From a policy point of view, the "Outline of the 14th Five-Year Plan for National Economic and Social Development of the People's Republic of China and the Long-Range Objectives Through the Year 2035" puts forward key tasks including the localization of medical devices; "Healthy China 2030" planning outline and "Made in China 2025" will promote the development of medical devices to the national development strategic position, in recent years, the country has continuously introduced favorable policies, at the policy level to give strong support to the industry, to encourage domestic medical devices to accelerate innovation, bigger and stronger.
FourthHistory
From the point of view of technology, in medicine, the ultrasonic nebulizer is called the first generation nebulizer, the compression nebulizer is called the second generation nebulizer, and the mesh nebulizer is the third generation nebulizer. There are obvious differences in the atomization mode, atomization particle size and use characteristics of different products.
At present, the ultrasonic nebulizer has formed a perfect industry standard "yy0109-2013", and there is still no relevant industry standard for compression and mesh nebulizers, mainly based on enterprise standards, with higher technical requirements. From the perspective of the evolution of industry technology, the overall development of industry technology is developing in the direction of stable airflow, uniform particles, convenient and efficient use.
FiveIndustry Risk
Regulatory risks in the industry
China's medical device industry is jointly supervised by the National Development and Reform Commission and the State Food and Drug Administration. The rapid development of the domestic medical device industry has also brought vicious competition and substandard products in the industry. Therefore, we will continue to strengthen the supervision and legislation of the medical industry, especially in terms of enterprise qualifications, production environment, equipment configuration and personnel quality. **Increasingly stringent regulations will have a certain impact on the business environment of the medical device industry, if the industry enterprises can not continue to have existing business qualifications or can not obtain the necessary business qualifications when launching new business, it will have an adverse impact on the business development and sustainable development of enterprises.
New product development risks
With the improvement of living standards, people's requirements for medical consumption are also getting higher and higher, and related companies need to continue to develop new products to meet the increasingly differentiated and personalized needs of customers, so as to occupy a favorable position in the fierce competitive environment. At present, although enterprises in the industry have increased their R&D efforts and actively introduced talents, they still cannot completely rule out the possibility that the existing technology of the enterprise is replaced by more advanced technology in the same industry at home and abroad, and the new products do not have competitive advantages in terms of technology, performance, cost, etc., or the new products developed do not meet the market development trend. If the new products developed by enterprises in the industry cannot meet the market demand, it will adversely affect the future business development of enterprises.
Raw material fluctuation risk
The raw materials required for the production of atomizers are mainly polypropylene, polycarbonate, polyvinyl chloride, plastic particles, etc., and the cost of raw materials accounts for a large proportion of the entire production cost. Therefore, the changes in raw materials such as polypropylene, polyvinyl chloride, polycarbonate, and plastic particles will have a great impact on the product cost of enterprises in the industry. In the past two years, the main raw materials as a whole fluctuate with the fluctuation of oil, if the raw materials appear, it will have an impact on the company's production and operation results and profitability.
SixIndustrial chain
The upstream of the nebulizer inhaler industry chain is mainly in the silicone rubber, plastic, electronics, steel, polyester fiber, and glass raw material industries, and the downstream is hospitals and pharmacies, and the terminals are patients and individual consumers.
In terms of upstream, the profit margin of the nebulizer inhaler industry as a whole is not high, and raw materials account for a relatively large proportion of the cost structure, which is greatly affected by upstream raw materials. In terms of downstream, in recent years, nebulized inhalation has benefited from the characteristics of correct administration location and fast effect, and the domestic nebulized inhaler market demand has increased significantly, especially in the field of children's market, the market has accelerated significantly, and the future development prospects are good.
Note:This article**Zhiyan Industry Encyclopediaplatform, if you need to get more industry information and customization, you can enterThe official website of Zhiyan ConsultingSearch to view.
Zhiyan Industry EncyclopediaIt is a production and research tool platform launched by Zhiyan Consulting, which is committed to providing you with a full range of encyclopedic industry information query services. Zhiyan ConsultingFulfill the corporate mission of using information to drive industrial development, improve and enrich the enterprise side, rely on the industry encyclopedia platform to enhance the value of information, and continue to empower industry development and enterprise investment decision-making. Nebulized inhalersIndustry encyclopedia asNebulized inhalersThe one-stop systematic research tool for the industry is comprehensively summarizedNebulized inhalersIndustry knowledge information, content covered:Nebulized inhalersIndustry definition, classification, policy, industrial chain, competitive landscape, development trend, etc., and rely on information technology to establish an intelligent interchain industry knowledge graph, to provide in-depth insight and comprehensive information for industry research practitioners and relevant investors.
Zhiyan ConsultingWith the brand concept of "using information to drive industrial development and empower enterprise investment decisions". Provide professional industrial consulting services for enterprises, the main services include:High-quality industry research reports, special customization, monthly topics, feasibility study reports, business plans, and industrial planningWait. and provideWeekly, Monthly, Quarterly, Annual Reportand other regular reports and customized data, covering policy monitoring, corporate dynamics, industry data, product changes, investment and financing overview, market opportunities and risk analysis, etc.